Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. CVAC.NASDAQ

CureVac NV (CVAC NASDAQ) stock market data APIs

$3.69 -0.03(-0.8%) as of July 26, 2024
Price chart is built with Anychart

CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202 which is in Phase 1 clinical trial for the treatment of rabies; and CVSQIV to treat multivalent seasonal influenza; Flu SV mRNA fot treating nucleotides, single antigen seasonal influenza. The company develops CV8102, which is in Phase 1 clinical trial for treating melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck; and CVGBM for treating cancer. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.

CureVac NV Financial Data Overview

3.72
3.69
-
3.74
3.6
2.215-10.14
816 M
224 M
59 002 K
-0.39
2.636
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CVAC',
Type: 'Common Stock',
Name: 'CureVac NV',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00W9LXXJ4',
ISIN: 'NL0015436031',
CUSIP: NULL,
CIK: '1809122',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2020-08-14',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

CureVac NV Fundamental Data is available in our Financial Data APIs

  • Net Revenue 59 002 K
  • EBITDA -270 816 000
  • Earnings Per Share -1.32
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get CureVac NV Earnings via APIs

  • Latest Release 2024-04-25
  • EPS/Forecast -0.18

Get CureVac NV End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get CureVac NV latest news via APIs

Down -14.25% in 4 Weeks, Here's Why You Should You Buy the Dip in CureVac N.V. (CVAC)

CureVac N.V. (CVAC) has been on a downward spiral lately with significant selling pressure. After declining 14.3% over the past four weeks, the stock looks well positioned for a trend reversal as it i...

Down -15.09% in 4 Weeks, Here's Why You Should You Buy the Dip in CureVac N.V. (CVAC)

A downtrend has been apparent in CureVac N.V. (CVAC) lately with too much selling pressure. The stock has declined 15.1% over the past four weeks. However, given the fact that it is now in oversold te...
Do you have any questions?
support@eodhistoricaldata.com